Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C InfectionPaul Y. Kwo, Barbara Haber, Edward Gane et al.|Gastroenterology|2016Cited by 173
Whole-genome sequencing reveals novel tandem-duplication hotspots and a prognostic mutational signature in gastric cancerRui Xing, Youyong Lu, Chao Yang et al.|Nature Communications|2019Cited by 90
901f Efficacy and Safety of Grazoprevir/Elbasvir ± Ribavirin (RBV) for 12 or 16 Weeks in Patients With HCV G1, G4, or G6 Infection Who Previously Failed Peginterferon/RBV: C-EDGE Treatment-Experienced TrialPaul Y. Kwo, Barbara Haber, Edward Gane et al.|Gastroenterology|2015Cited by 16